PROBNP II, N-TERMINAL PRO B-TYPE NATRIURETIC PEPTIDE 04842464190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2018-06-29 for PROBNP II, N-TERMINAL PRO B-TYPE NATRIURETIC PEPTIDE 04842464190 manufactured by Roche Diagnostics.

Event Text Entries

[112895766] Unique identifier (udi)#: (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[112895767] The customer stated that they received erroneous results for two samples from the same patient tested for the elecsys probnp ii immunoassay (probnp) on the customer's cobas 6000 e 601 module (e601). One additional sample from the same patient had an erroneous probnp result when tested on a cobas 8000 e 602 module (e602) and a cobas e 411 immunoassay analyzer (e411) used for investigation. The erroneous results were reported outside of the laboratory. The patient data suggested that the patient has a mutation of the nt-probnp fragment, which is detected by the probnp assay. The patient had a sample collected and it was tested at another hospital on (b)(6) 2018 with an unknown bnp assay, resulting as 4838 pg/ml. A second sample was collected from the patient and tested on the customer's e601 analyzer on (b)(6) 2018, resulting with a probnp value of < 5 pg/ml. A third sample was collected from the patient and tested at another hospital on (b)(6) 2018 with an unknown bnp assay, resulting as 2250 pg/ml. This sample was repeated on the customer's e601 analyzer on (b)(6) 2018, resulting with a probnp value of < 5 pg/ml. A fourth sample was collected from the patient on (b)(6) 2018 and provided for investigation, where it was tested on an e602 analyzer and an e411 analyzer. The probnp result from each analyzer was < 5. 0 pg/ml. No adverse events were alleged to have occurred with the patient. The serial number of the customer's e601 analyzer is (b)(4). The serial numbers of the e602 and e411 analyzers used for investigation were asked for, but not provided.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1823260-2018-02104
MDR Report Key7649707
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2018-06-29
Date of Report2018-07-31
Date of Event2018-05-21
Date Mfgr Received2018-06-12
Date Added to Maude2018-06-29
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NamePROBNP II, N-TERMINAL PRO B-TYPE NATRIURETIC PEPTIDE
Generic NameTEST,NATRIURETIC PEPTIDE
Product CodeNBC
Date Received2018-06-29
Model NumberNA
Catalog Number04842464190
Lot Number227748
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2018-06-29

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.